2016 was an outstanding year for us, having made seven calls with successes on five of them:
KBS Fashion Group Limited (KBSF) : KBSF Was the only loser as a long call, with a buy call on the morning of June 24 When It traded at $ 0.41 on the previous day. Now it's $ 0.31 for an overall decline of 24% , aim for a microcap That Is not that much of a loss with more volatile trading Such has-been there plenty of Opportunities to take a gain.
Neovasc Inc. (NVCN) : NVCN Was a huge winner, as we first called Expired it on July 15, 2016 , When It was trading at $ 0.46. We Predicted que le stock will return to the $ 2 level, and it closed on December 23 at $ 1.92, a 317% gain .
Professional Diversity Network, Inc. (IPDN) : Was an easy IPDN buy call for us on August 15 at 0.72 partner after the announcement of a stock purchase agreement at $ 1.20, and we felt upside That Was Easy To That year price. The stock had a 1-for-8 reverse split and sits at $ 10.06 now, or $ 1.26 pre-split, 6 cents above the agreement price. A 75% gain .
KBS Fashion Group Limited (KBSF) : KBSF Was the only loser as a long call, with a buy call on the morning of June 24 When It traded at $ 0.41 on the previous day. Now it's $ 0.31 for an overall decline of 24% , aim for a microcap That Is not that much of a loss with more volatile trading Such has-been there plenty of Opportunities to take a gain.
Neovasc Inc. (NVCN) : NVCN Was a huge winner, as we first called Expired it on July 15, 2016 , When It was trading at $ 0.46. We Predicted que le stock will return to the $ 2 level, and it closed on December 23 at $ 1.92, a 317% gain .
Professional Diversity Network, Inc. (IPDN) : Was an easy IPDN buy call for us on August 15 at 0.72 partner after the announcement of a stock purchase agreement at $ 1.20, and we felt upside That Was Easy To That year price. The stock had a 1-for-8 reverse split and sits at $ 10.06 now, or $ 1.26 pre-split, 6 cents above the agreement price. A 75% gain .
Portola Pharmaceuticals, Inc. (PTLA) : We felt PTLA That Was a strong buyout target if it has Remained cheap due to mis-management steps, on August 24 at a price of $ 20.41 . The stock rose 33% on Friday partner after the FDA finally accepted the new drug application, and sits at $ 25.06 or 23% gain from our call price.
Lpath, Inc. (LPTN) : We called Expired LPTN a buy on September 10 , Having closed at $ 2.68 the previous day. It has-been a very volatile stock sits at $ 3.13 order now for a 17% gain .
Supernus Pharmaceuticals, Inc. (SUPN) : We called Expired SUPN a pharmaceutical unicorn and a buy on October 12 , When It was trading at $ 21.54. It's now $ 25.60, or a 19% gain .
Aerie Pharmaceuticals, Inc. (AERI) : We called Expired AERI as a short on October 16 , at $ 37.29. It's $ 38.65, or up about 4%, but in the context of the Trump rally that is not very noteworthy move. Compare AERI's increase of 4% versus the moves on PTLA and SUPN and it was definitely better in biotech than AERI at the time and going forward.
You can follow any responses to this entry through the RSS 2.0 feed. Some people have called this a pump and dump blog but compared to the so-called pundits on CNBC I think that we stack up rather well. 67 people-have Followed this blog since we added functions on this in August , and for good reason. You can follow this post by clicking the button in the top left panel.
Stay tuned for more picks in 2017.
If you are interested in penny stock picks, check out Microcap Millionaires
If you're interested in trading options, both, calls and puts on some large cap stocks, check out binaryoptionsprosignals.com
Learn to trade stocks, options, commodities and forex Profitably with Trader Review
If you are interested in dividend stocks and return analysis, Then dividendstocksonline.com gold Dividend Stocks Rock are for you.
If you're interested in gold, this WSW special report or the Goldmasterinvesting.com Ocean Of Gold Report are for you
No comments:
Post a Comment